This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stocks in Motion

Shares of Nabi Biopharmaceuticals (NABI) were among the worst-performing health-related stocks Tuesday, tumbling nearly 72% after the biotechnology company halted development of its staph infection vaccines.

The company decided to discontinue developing the vaccines after its StaphVax product failed to meet the primary endpoint of a Phase III trial. The study found no reduction in S. aureus types 5 and 8 infections in the StaphVax group of patients as compared to a placebo group. "We are obviously surprised and very disappointed with the results of the StaphVax confirmatory Phase III trial," the company said.

In addition to halting further development of StaphVax and withdrawing its application to market StaphVax in the European Union, Nabi said it would also halt development of Altastaph, the company's investigational product for the prevention and treatment of S. aureus infections. Shares were trading down $9.25 to $3.60.

Allergan (AGN - Get Report) rose 8% after the eye-care products company posted better-than-expected third-quarter results. The company earned $150.5 million, or $1.12 a share, on sales of $606.1 million. Excluding items, Allergan have earned $112.1 million, or 83 cents a share. Analysts polled by Thomson First Call expected earnings, before items, of 79 cents a share, and sales of $569.6 million. A year earlier, Allergan earned $92 million, or 69 cents a share, on sales of $510.8 million. Excluding items, the company would have earned $89 million, or 67 cents a share, in the year-ago period.

Looking ahead, Allergan forecast fourth-quarter earnings of 88 cents to 89 cents a share, in line with analysts' forecast of 89 cents. The company sees sales of $565 million to $580 million, bracketing analysts' mean estimate of $570 million. Shares recently were up $6.74 to $96.04.

Shares of Health Net (HNT) rose 1% after the company posted third-quarter results that topped forecasts. The managed-health care company earned $78.2 million, or 67 cents a share, on sales of $3.06 billion. Analysts projected earnings of 64 cents a share, with sales of $3.04 billion. A year earlier, Health Net earned $71.9 million, or 64 cents a share, on sales of $2.94 billion.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
NABI $10.80 0.00%
AMED $49.62 1.20%
AGN $209.90 -2.20%
HNT $67.19 3.67%
MRK $54.09 -1.30%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs